questionText: To ask the Secretary of State for Health and Social Care, whether his Department made an impact assessment of the effect of NICE’s severity modifier, introduced in 2020, on the ability of cancer medicines to meet the new ‘high severity’ threshold for approval.
answerText: The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended ...
heading: Cancer: Drugs